Cargando…

Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity

The gut microbiota is now considered as a key player in the development of metabolic dysfunction. Therefore, targeting gut microbiota dysbiosis has emerged as a new therapeutic strategy, notably through the use of live gut microbiota-derived biotherapeutics. We previously highlighted the anti-inflam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuffaro, Bernardo, Boutillier, Denise, Desramaut, Jérémy, Jablaoui, Amin, Werkmeister, Elisabeth, Trottein, François, Waligora-Dupriet, Anne-Judith, Rhimi, Moez, Maguin, Emmanuelle, Grangette, Corinne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177344/ https://www.ncbi.nlm.nih.gov/pubmed/37174660 http://dx.doi.org/10.3390/cells12091260

Ejemplares similares

In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of Parabacteroides distasonis Strains Alleviating TNBS-Induced Colitis in Mice
por: Cuffaro, Bernardo, et al.
Publicado: (2020)

Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria
por: Cuffaro, Bernardo, et al.
Publicado: (2021)

Parabacteroides distasonis Properties Linked to the Selection of New Biotherapeutics
por: Chamarande, Jordan, et al.
Publicado: (2022)

Multiple Selection Criteria for Probiotic Strains with High Potential for Obesity Management
por: Alard, Jeanne, et al.
Publicado: (2021)

Diet Supplementation with NUTRIOSE, a Resistant Dextrin, Increases the Abundance of Parabacteroides distasonis in the Human Gut
por: Thirion, Florence, et al.
Publicado: (2022)

Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a
por: Sun, Yonggan, et al.
Publicado: (2023)

Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid
por: Wei, Wenchao, et al.
Publicado: (2023)

Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health
por: Bourgin, Mélanie, et al.
Publicado: (2021)

Polyclonal Aptamers for Specific Fluorescence Labeling and Quantification of the Health Relevant Human Gut Bacterium Parabacteroides distasonis
por: Xing, Hu, et al.
Publicado: (2021)

In Silico Study of Cell Surface Structures of Parabacteroides distasonis Involved in Its Maintenance within the Gut Microbiota
por: Chamarande, Jordan, et al.
Publicado: (2022)

Surface Properties of Parabacteroides distasonis and Impacts of Stress-Induced Molecules on Its Surface Adhesion and Biofilm Formation Capacities
por: Chamarande, Jordan, et al.
Publicado: (2021)

Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health
por: Ezeji, Jessica C., et al.
Publicado: (2021)

Microbial impact on cholesterol and bile acid metabolism: current status and future prospects
por: Kriaa, Aicha, et al.
Publicado: (2019)

The Nexus of Diet, Gut Microbiota and Inflammatory Bowel Diseases in Dogs
por: Rhimi, Soufien, et al.
Publicado: (2022)

Gut Serpinome: Emerging Evidence in IBD
por: Mkaouar, Héla, et al.
Publicado: (2021)

SP-1, a Serine Protease from the Gut Microbiota, Influences Colitis and Drives Intestinal Dysbiosis in Mice
por: Kriaa, Aicha, et al.
Publicado: (2021)

Bile Acids: Key Players in Inflammatory Bowel Diseases?
por: Kriaa, Aicha, et al.
Publicado: (2022)

Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice
por: Dziarski, Roman, et al.
Publicado: (2016)

Indoleacrylic acid produced by Parabacteroides distasonis alleviates type 2 diabetes via activation of AhR to repair intestinal barrier
por: Liu, Deliang, et al.
Publicado: (2023)

Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice
por: Zhao, Qi, et al.
Publicado: (2023)

Serine protease inhibitors and human wellbeing interplay: new insights for old friends
por: Mkaouar, Héla, et al.
Publicado: (2019)

Serine proteases and metalloproteases are highly increased in irritable bowel syndrome Tunisian patients
por: Soussou, Souha, et al.
Publicado: (2023)

Domestic Environment and Gut Microbiota: Lessons from Pet Dogs
por: Hernandez, Juan, et al.
Publicado: (2022)

Classification of Parabacteroides distasonis and other Bacteroidetes using O- antigen virulence gene: RfbA-Typing and hypothesis for pathogenic vs. probiotic strain differentiation
por: Bank, Nicholas C., et al.
Publicado: (2022)

Fecal Serine Protease Profiling in Inflammatory Bowel Diseases
por: Jablaoui, Amin, et al.
Publicado: (2020)

Complete Genome Sequence of a Parabacteroides distasonis Strain (CavFT hAR46) Isolated from a Gut Wall-Cavitating Microlesion in a Patient with Severe Crohn’s Disease
por: Yang, Falong, et al.
Publicado: (2019)

Long-term high-fructose high-fat diet feeding elicits insulin resistance, exacerbates dyslipidemia and induces gut microbiota dysbiosis in WHHL rabbits
por: Moughaizel, Michelle, et al.
Publicado: (2022)

Digestive Inflammation: Role of Proteolytic Dysregulation
por: Mariaule, Vincent, et al.
Publicado: (2021)

The acid-tolerant L-arabinose isomerase from the mesophilic Shewanella sp. ANA-3 is highly active at low temperatures
por: Rhimi, Moez, et al.
Publicado: (2011)

Parabacteroides pacaensis sp. nov. and Parabacteroides provencensis sp. nov., two new species identified from human gut microbiota
por: Benabdelkader, S., et al.
Publicado: (2020)

Exploring the Bacterial Impact on Cholesterol Cycle: A Numerical Study
por: Bourgin, Mélanie, et al.
Publicado: (2020)

Indole, a Signaling Molecule Produced by the Gut Microbiota, Negatively Impacts Emotional Behaviors in Rats
por: Jaglin, Mathilde, et al.
Publicado: (2018)

Sildenafil citrate long-term treatment effects on cardiovascular reactivity in a SHR experimental model of metabolic syndrome
por: Doghri, Yosra, et al.
Publicado: (2019)

Spray-drying process preserves the protective capacity of a breast milk-derived Bifidobacterium lactis strain on acute and chronic colitis in mice
por: Burns, Patricia, et al.
Publicado: (2017)

Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases
por: Mkaouar, Héla, et al.
Publicado: (2016)

The secreted l-arabinose isomerase displays anti-hyperglycemic effects in mice
por: Rhimi, Moez, et al.
Publicado: (2015)

Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate
por: Salvat, Regina S., et al.
Publicado: (2015)

Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis
por: Hrdý, Jiří, et al.
Publicado: (2022)

Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)

Integrated BioTherapeutics
por: Aman, M. Javad
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ug5f0sa9g43q1mqkhf46gi76h7